Literature DB >> 17266557

Impact of human immune deficiency virus infection on hepatitis C virus infection and replication.

Cecilia Parodi1, Liliana Belmonte, Patricia Baré, María M E de Bracco, Beatriz Ruibal-Ares.   

Abstract

Human immune deficiency virus (HIV) and human hepatitis C virus (HCV) infection are frequent in patients who have been exposed to blood or blood-derived products. It has been suggested that HIV infection increases HCV replication altering the course of HCV-related disease. However, it is not known if HIV directly enhances HCV replication or if its effect is the consequence of HIV infection of other cell types that control HCV replication (lymphocytes, macrophages). While the main cell targets for HIV infection are mononuclear leukocytes bearing CD4 and the chemokine receptors CCR5 and CXCR4, HCV was originally thought to be strictly hepatotropic, but it is now known that HCV can also replicate in peripheral blood mononuclear cells (PBMC). Therefore, in co-infected individuals, these two different viruses could share cell targets and interact either directly or indirectly. Some membrane receptors can be used by both HCV and HIV for entry into target cells, but the intracellular mechanisms shared by these viruses are not known. Lack of experimental systems providing suitable methods for the study of HCV replication in the presence or absence of HIV co-infection has hampered advances in this research area, but recent investigations are currently going on in order to answer these questions. This is an important issue, as knowledge of HIV/HCV interactions is required for the design of effective antiviral therapies.

Entities:  

Mesh:

Year:  2007        PMID: 17266557     DOI: 10.2174/157016207779316341

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  7 in total

1.  Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikunar Aalinkeel; B Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2009       Impact factor: 3.657

Review 2.  Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options.

Authors:  Sayed Sartaj Sohrab; Mohd Suhail; Ashraf Ali; Ishtiaq Qadri; Steve Harakeh; Esam I Azhar
Journal:  Virusdisease       Date:  2018-01-27

3.  The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10.

Authors:  Jing Qu; Qi Zhang; Youxing Li; Weiyong Liu; Lvxiao Chen; Ying Zhu; Jianguo Wu
Journal:  BMC Immunol       Date:  2012-04-03       Impact factor: 3.615

4.  Crosstalk between HIV and hepatitis C virus during co-infection.

Authors:  Paul J Rider; Fenyong Liu
Journal:  BMC Med       Date:  2012-04-03       Impact factor: 8.775

5.  HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication.

Authors:  Milin Peng; Xinqiang Xiao; Yan He; Yongfang Jiang; Min Zhang; Feng Peng; Yi Tian; Yun Xu; Guozhong Gong
Journal:  J Gen Virol       Date:  2015-04-28       Impact factor: 3.891

6.  Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targets.

Authors:  Julia A Najera; Eduardo A Bustamante; Nikki Bortell; Brenda Morsey; Howard S Fox; Timothy Ravasi; Maria Cecilia Garibaldi Marcondes
Journal:  BMC Immunol       Date:  2016-04-23       Impact factor: 3.615

7.  Porphyromonas gingivalis induces CCR5-dependent transfer of infectious HIV-1 from oral keratinocytes to permissive cells.

Authors:  Rodrigo A Giacaman; Anil C Asrani; Kristin H Gebhard; Elizabeth A Dietrich; Anjalee Vacharaksa; Karen F Ross; Mark C Herzberg
Journal:  Retrovirology       Date:  2008-03-27       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.